MINNEAPOLIS, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) is pleased to announce that its Skyline Medical division, producer of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback